Overall rank by patents
#3,087
Across all tracked assignees
USPTO PatentsView assignee record - 123 granted patents across 51 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08F (MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS).
The verdict
W.r. holds 123 US patents across 51 technology areas, rank #3,087 of 50,000 tracked assignees.
W.r. Grace & Co.-conn. has been granted 123 US utility patents between 2015 and 2025, placing W.r. Grace & Co.-conn. at rank #3,087 across all assignees tracked by PlainPatent. This portfolio spans 51 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in C08F (MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS). As a US Corporation, W.r. Grace & Co.-conn. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, W.r. sits between Lifetime Products, Inc. (123 patents, rank #3,083) and CVS Pharmacy, Inc. (122 patents, rank #3,091) - the closest US assignees by grant volume. The composite Innovation Score of 58.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 59 grants, compared with 64 in the 2015–2019 window, a -8% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. W.r. Grace & Co.-conn.'s 18.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 51 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark W.r. Grace & Co.-conn. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
LIFETIME PRODUCTS, INC.
123 patents
MPI CORPORATION
123 patents
May Patents Ltd.
123 patents
SORAA, INC.
123 patents
W.R. Grace & Co.-Conn.
123 patents
ARM IP LIMITED
122 patents
Anker Innovations Technology Co., Ltd.
122 patents
BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS
122 patents
CVS PHARMACY, INC.
122 patents
What this shows W.r. holds 123 patents at rank #3,087, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,087 in granted patent volume.
Other assignees with the most granted patents in Wr's primary technology class.
W.r.'s Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
58 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 13 | 10.6% |
| 2016 | 15 | 12.2% |
| 2017 | 16 | 13.0% |
| 2018 | 10 | 8.1% |
| 2019 | 10 | 8.1% |
| 2020 | 11 | 8.9% |
| 2021 | 11 | 8.9% |
| 2022 | 14 | 11.4% |
| 2023 | 6 | 4.9% |
| 2024 | 8 | 6.5% |
| 2025 | 9 | 7.3% |
Top 15 of 51 technology areas
Overall rank by patents
#3,087
Across all tracked assignees
58.3 out of 100
How to use this portfolio
W.r.'s 123 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.